{
    "root": "4564e404-8d71-4585-ab78-55857f477143",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate",
    "value": "20250510",
    "ingredients": [
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "AMPHETAMINE SULFATE",
            "code": "6DPV8NK46S",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_51063"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "AMPHETAMINE ASPARTATE",
            "code": "H527KAP6L5",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2679"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE 102",
            "code": "PNR0YF693Y",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "SACCHARIN SODIUM",
            "code": "SB8ZUX40TY",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32112"
        },
        {
            "name": "DEXTROAMPHETAMINE SACCHARATE",
            "code": "G83415V073",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01576"
        },
        {
            "name": "DEXTROAMPHETAMINE SULFATE",
            "code": "JJ768O327N",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "MALTODEXTRIN",
            "code": "7CVR7L4A2D",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25140"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        }
    ],
    "indications": {
        "text": "dextroamphetamine saccharate , amphetamine aspartate , dextroamphetamine sulfate amphetamine sulfate tablets indicated treatment attention deficit hyperactivity disorder ( adhd ) narcolepsy .",
        "doid_entities": [
            {
                "text": "attention deficit hyperactivity disorder (DOID:1094)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1094"
            },
            {
                "text": "narcolepsy (DOID:8986)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8986"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "regardless indication , amphetamines administered lowest effective , individually adjusted according therapeutic needs response patient . late evening doses avoided resulting insomnia .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "dextroamphetamine saccharate , amphetamine aspartate , dextroamphetamine sulfate amphetamine sulfate tablets supplied follows : 5 mg : white white , round , biconvex quadrisect tablet debossed one side \u201c 5 \u201d upper left quadrant . side quadrisected debossed np007 . bottles 100 tablets ndc 68462-647-01 10 mg : white white , round , biconvex quadrisect tablet debossed one side \u201c 10 \u201d separated bisect upper quadrant . side quadrisected debossed np008 . bottles 100 tablets ndc 68462-649-01 15 mg : orange , round , biconvex quadrisect tablet debossed one side \u201c 15 \u201d separated bisect upper quadrant . side quadrisected debossed np009 . bottles 100 tablets ndc 68462-651-01 20 mg : orange , round , biconvex quadrisect tablet debossed one side \u201c 20 \u201d separated bisect upper quadrant . side quadrisected debossed np010 . bottles 100 tablets ndc 68462-652-01 30 mg : orange , round , biconvex quadrisect tablet debossed one side \u201c 30 \u201d separated bisect upper quadrant . side quadrisected debossed np011 . bottles 100 tablets ndc 68462-653-01 dispense tight , light-resistant container . store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . medication guide available www.glenmarkpharma-us.com/medguides manufactured : neolpharma , inc. caguas , puerto rico 00725 , usa distributed : glenmark pharmaceuticals inc. , usa mahwah , nj 07430 issued 05/25 pp64701",
    "adverseReactions": "patients known hypersensitive amphetamine , components dextroamphetamine saccharate , amphetamine aspartate , dextroamphetamine sulfate amphetamine sulfate tablets . hypersensitivity angioedema anaphylactic reported patients treated amphetamine products [ ] . patients taking monoamine oxidase inhibitors ( maois ) , within 14 days stopping maois ( including maois linezolid intravenous methylene blue ) , increased risk hypertensive crisis [ ] .",
    "indications_original": "Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.",
    "contraindications_original": "Regardless of indication, amphetamines should be administered at the lowest effective dosage, and dosage should be individually adjusted according to the therapeutic needs and response of the patient. Late evening doses should be avoided because of the resulting insomnia.",
    "warningsAndPrecautions_original": "Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are supplied as follows:\n                  5 mg: A white to off white, round, biconvex quadrisect tablet debossed on one side with \u201c5\u201d in the upper left quadrant. The other side is quadrisected and debossed with NP007.\n                  Bottles of 100 Tablets NDC 68462-647-01\n                  10 mg: A white to off white, round, biconvex quadrisect tablet debossed on one side with \u201c10\u201d separated by a bisect in the upper quadrant. The other side is quadrisected and debossed with NP008.\n                  Bottles of 100 Tablets NDC 68462-649-01\n                  15 mg: An orange, round, biconvex quadrisect tablet debossed on one side with \u201c15\u201d separated by a bisect in the upper quadrant. The other side is quadrisected and debossed with NP009.\n                  Bottles of 100 Tablets NDC 68462-651-01\n                  20 mg: An orange, round, biconvex quadrisect tablet debossed on one side with \u201c20\u201d separated by a bisect in the upper quadrant. The other side is quadrisected and debossed with NP010.\n                  Bottles of 100 Tablets NDC 68462-652-01\n                  30 mg: An orange, round, biconvex quadrisect tablet debossed on one side with \u201c30\u201d separated by a bisect in the upper quadrant. The other side is quadrisected and debossed with NP011.\n                  Bottles of 100 Tablets NDC 68462-653-01\n                  Dispense in a tight, light-resistant container.\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [See USP Controlled Room Temperature].\n                  \n                     Medication Guide available at\n                  \n                  \n                     www.glenmarkpharma-us.com/medguides\n                  \n                  Manufactured by:\n                  Neolpharma, Inc.\n                  Caguas, Puerto Rico 00725, USA\n                  Distributed by:\n                  \n                  \n                     Glenmark Pharmaceuticals Inc., USA\n                  \n                  Mahwah, NJ 07430\n                  Issued 05/25\n                  PP64701",
    "adverseReactions_original": "In patients known to be hypersensitive to amphetamine, or other components of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets.    Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products [see ADVERSE REACTIONS].  \n                  Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis [see WARNINGS and DRUG INTERACTIONS].",
    "drug": [
        {
            "name": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2679"
        }
    ]
}